ICAM1 and lung carcinoma: As TIMP-1 upregulation is prevented by ICAM-1 neutralizing antibodies or silencing microRNA, the authors concluded that the cellular adhesion and signaling molecule ICAM-1 are implicated in the beneficial effects of cannabinoid compounds on lung cancer.